CORMEDIX INC.

Lobbying client · New Jersey · filed 2025 to 2026

Biopharmaceutical company.

$1,250,000 Reported spend

6 Filings counted

1 Firms hired

6 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (56832), not by name.

Firms hired 1

CORMEDIX INC. $1,250,000 6 filings

Bills named in these filings 6

S 2730
Kidney Care Access Protection Act

4 filings
HR 6214
Kidney Care Access Protection Act

3 filings
HR 7352
PASTEUR Act of 2026

2 filings
S 4815
CHIP IN for Veterans Act of 2026

2 filings
HR 2172
Preserving Patient Access to Home Infusion Act

1 filing
S 1058
Preserving Patient Access to Home Infusion Act

1 filing

Reported by year 2 years

2026 $600,000 2 filings
2025 $650,000 4 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 6 total

Q2

CORMEDIX INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $220,000 expenses · posted Jul 31, 2026

View → Q1

CORMEDIX INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $380,000 expenses · posted Jul 2, 2026

View → Q4

CORMEDIX INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $150,000 expenses · posted Feb 5, 2026

View → Q3

CORMEDIX INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $150,000 expenses · posted Oct 20, 2025

View → Q2

CORMEDIX INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $150,000 expenses · posted Jul 31, 2025

View → Q1

CORMEDIX INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $200,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.